Hoth Therapeutics Correlations
HOTH Stock | USD 1.25 0.09 6.72% |
The current 90-days correlation between Hoth Therapeutics and Plus Therapeutics is -0.02 (i.e., Good diversification). The correlation of Hoth Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Hoth Therapeutics Correlation With Market
Average diversification
The correlation between Hoth Therapeutics and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hoth Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Hoth Stock
0.81 | PFE | Pfizer Inc | PairCorr |
0.71 | KMDA | Kamada | PairCorr |
0.77 | CAT | Caterpillar | PairCorr |
0.71 | AXP | American Express | PairCorr |
0.69 | BA | Boeing | PairCorr |
0.77 | CSCO | Cisco Systems | PairCorr |
0.69 | XOM | Exxon Mobil Corp | PairCorr |
0.74 | JPM | JPMorgan Chase | PairCorr |
0.77 | MSFT | Microsoft | PairCorr |
0.69 | DD | Dupont De Nemours | PairCorr |
0.73 | GE | GE Aerospace Earnings Call This Week | PairCorr |
0.8 | IBM | International Business Earnings Call This Week | PairCorr |
Moving against Hoth Stock
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Hoth Stock performing well and Hoth Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hoth Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ADTX | 4.38 | (1.11) | 0.00 | (1.06) | 0.00 | 12.50 | 37.30 | |||
PALI | 3.23 | 0.13 | 0.01 | 0.47 | 3.55 | 7.25 | 18.72 | |||
PSTV | 8.85 | (0.18) | (0.01) | 0.01 | 10.27 | 23.44 | 81.93 | |||
REVB | 4.85 | (1.44) | 0.00 | (3.40) | 0.00 | 9.33 | 61.31 | |||
QNRX | 3.37 | 0.77 | 0.19 | 2.17 | 3.07 | 9.33 | 26.24 | |||
SONN | 11.05 | 4.66 | 0.77 | (174.97) | 4.09 | 13.79 | 254.85 | |||
PHIO | 5.13 | 0.44 | 0.04 | (1.19) | 5.86 | 16.96 | 31.79 |
Hoth Therapeutics Corporate Management
Jane Springer | VP Operations | Profile | |
Hayley Springer | Executive Operations | Profile | |
Stefanie Johns | Chief Officer | Profile | |
David Briones | Chief Officer | Profile |